These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15327424

  • 1. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U.
    Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
    [Abstract] [Full Text] [Related]

  • 2. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
    Song E, Zou H, Yao Y, Proudfoot A, Antus B, Liu S, Jens L, Heemann U.
    Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 5. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U.
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [Abstract] [Full Text] [Related]

  • 6. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
    Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Krämer S, Neumayer HH.
    Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
    [Abstract] [Full Text] [Related]

  • 7. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.
    Koch M, Poehnert D, Nashan B.
    Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360
    [Abstract] [Full Text] [Related]

  • 8. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
    Dragun D, Böhler T, Nieminen-Kelhä M, Waiser J, Schneider W, Haller H, Luft FC, Budde K, Neumayer HH.
    Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
    [Abstract] [Full Text] [Related]

  • 9. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S, Binder E, Loof T, Wang-Rosenke Y, Martini S, Khadzhynov D, Budde K, Neumayer HH, Peters H.
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [Abstract] [Full Text] [Related]

  • 10. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K, Birnbaum F, Reinhard T, Reis A, Braunstein S, Claas F, Sundmacher R.
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [Abstract] [Full Text] [Related]

  • 11. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 12. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 13. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T, Okada A.
    Transplantation; 2003 May 15; 75(9):1469-74. PubMed ID: 12792499
    [Abstract] [Full Text] [Related]

  • 14. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 15; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 15. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
    Yanagawa Y, Hoshino Y, Chiba K.
    Int J Immunopharmacol; 2000 Aug 15; 22(8):597-602. PubMed ID: 10988354
    [Abstract] [Full Text] [Related]

  • 16. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
    Hirt SW, von Suesskind-Schwendi M, Puehler T, Schmid C, Lehle K.
    Transplant Proc; 2013 Mar 15; 45(2):783-6. PubMed ID: 23498820
    [Abstract] [Full Text] [Related]

  • 17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 18. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
    Li XK, Tamura A, Fujino M, Guo L, Kakefuda T, Funeshima N, Enosawa S, Amari M, Naoe S, Amemiya H, Suzuki S.
    Clin Exp Immunol; 2001 Feb 15; 123(2):331-9. PubMed ID: 11207666
    [Abstract] [Full Text] [Related]

  • 19. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH.
    Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.